MORGAN STANLEY PLC/CALL/AGILENT TECHNOLOGIES/160/0.1/20.12.24 Stock

Warrant

DE000ME9GXE1

Market Closed - Börse Stuttgart 12:28:40 2024-07-12 pm EDT
0.25 EUR +17.37% Intraday chart for MORGAN STANLEY PLC/CALL/AGILENT TECHNOLOGIES/160/0.1/20.12.24
Current month+4.17%
1 month-19.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.25 +17.37%
24-07-11 0.213 +18.99%
24-07-10 0.179 +6.55%
24-07-09 0.168 -7.18%
24-07-08 0.181 0.00%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 12:28 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying AGILENT TECHNOLOGIES, INC.
Issuer Morgan Stanley
WKN ME9GXE
ISINDE000ME9GXE1
Date issued 2024-03-01
Strike 160 $
Maturity 2024-12-20 (160 Days)
Parity 10 : 1
Emission price 0.76
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.27
Lowest since issue 0.168
Spread 0.03
Spread %11.54%

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).
Sector
-
More about the company

Ratings for Agilent Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Agilent Technologies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
132.2 USD
Average target price
141 USD
Spread / Average Target
+6.66%
Consensus